causal

US taxpayer funds global drug innovation via unconstrained pricing

An enormous portion of pharmaceutical profitability comes from unconstrained pricing that Medicare pays out of American taxpayers' pockets; other countries (Israel, France, England, Romania) pay far less, so the drug would not exist without the large profit opportunity in America, meaning US taxpayers effectively subsidize cheaper drugs worldwide.

causalpending

Speaker

Russ Roberts

Evidence Quote

“that drug wouldn't exist without that enormous opportunity in America to make a lot of money.”

Source

Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty— EconTalk
Created: 6/13/2026, 3:32:57 AM

Your notes

Loading notes...